>0%
First-pass acceptance
Complete on arrival · complex global ICSR mixPharmacovigilance automation
Your procedure. Any volume.
Your sign-off.
NOESIS is the safety intelligence layer across your pharmacovigilance operation. It runs the procedure your team already validated, at any volume, and every case reaches your reviewer complete, every value traced to source.
2000In production>0Audits cleared9Findings on NOESISSeven modules.
One platform.
Configured
From the mailbox to the aggregate report, every module reads one configuration: yours.
Hosted in the EU · Microsoft Azure, North and West Europe
Success Metrics
Measured in Production, by the People who run it.
In production
Delivered as E2B(R3) into Argus, LifeSphere or Any Safety Database.
Most operations run a stack: mailboxes, translators and processing systems from every company they have bought, each configured on its own and reconciled by hand before an inspection.
- Change your procedure once. It holds everywhere.
- Clean data leaves for any safety database.
- One audit trail. One company answerable.
After an acquisition
Two operations. Two sets of conventions. One inspection.
What arrives with an acquisition is a second processing centre with conventions of its own. Documents and languages can differ by country, and that is fine. The procedure cannot.
If you run pharmacovigilance as a service
Automate onshore and offshore alike,
and every client’s procedure still runs as written.
The bids you can answer stop being limited by the mix you can process.
>90%
First-pass acceptance on a complex ICSR mix · more than 90,000 cases a year · measured at one sponsor
If you hold the marketing authorisation
Any volume the acquisition brings, on one procedure. Your reviewers make every medical judgment, the same way they do today.
What you add is capacity. The procedure, the validated state and your reviewers stay where they are.
3x
Surge capacity, absorbed · one global sponsor · complex ICSR mix including novel drug-devices
Why NOESIS
Inspected. Proven. Sovereign. Rapid.
Scaled capacity with proven completeness: the procedure you validated, run at any volume, every case complete and traced to source, at a price that does not move with volume.
Safety intelligence
One layer between every source and your safety database.
NOESIS is the safety intelligence layer: the layer between every source your operation receives and the safety databases it runs, where your procedure is applied, every value is traced, and the data is harmonised.
Drogevate
AI built to be inspected.
The company behind NOESIS. Drogevate builds it, runs it and answers for it in your audit trail, whoever delivers it. One team, from the first configuration to the inspection.
Download the security and validation summary
Founded:- 2019 · in production since May 2024
Funding:- Profitable and self-funded, with no external investor timeline forcing an exit or pivot
Retention:- 96% of customers retained
- Hosting:
- Microsoft Azure, North and West Europe. Your data stays in the EU.
Certification:- ISO 27001:2022
The team
The people who built NOESIS, and the years in pharmacovigilance behind each of them, from case intake to inspection.
Anil Bansal
Founder, Vice President - Technology & Development
21 years in Life Sciences & Healthcare Technology
See NOESIS on your own case mix.
A handful of the cases you actually receive is enough, and the complex ones tell you the most. Each value comes back with its page and line, and each field NOESIS held for your reviewer is marked.
Or start with a paid assessment on your own cases. 6 to 8 weeks, 200 to 300 cases, and the fee is credited if you go ahead.